Pacira BioSciences, Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $158.5M | $276.8M | $153.3M | $104.1M | $585.6M | $100.0M | $78.2M | $132.5M |
| Accounts Receivable | $124.1M | $113.3M | $105.6M | $98.4M | $96.3M | $53.0M | $47.5M | $38.0M |
| Inventory | $152.9M | $125.3M | $104.4M | $96.1M | $98.6M | $64.7M | $58.3M | $48.6M |
| Total Current Assets | $548.0M | $745.1M | $510.0M | $498.3M | $866.0M | $651.6M | $408.6M | $478.0M |
| Property, Plant & Equipment | $140.7M | $167.2M | $173.9M | $183.5M | $188.4M | $136.7M | $104.7M | $108.7M |
| Goodwill | $20.2M | $0 | $163.2M | $163.2M | $145.2M | $99.5M | $99.5M | $62.0M |
| Intangible Assets (Excl. Goodwill) | $368.1M | $426.0M | $483.3M | $540.5M | $624.0M | $96.5M | $104.4M | $0 |
| Total Assets | $1.26B | $1.55B | $1.57B | $1.68B | $2.08B | $1.27B | $831.1M | $689.4M |
| Liabilities | ||||||||
| Accounts Payable | $15.2M | $19.1M | $15.7M | $15.2M | $10.5M | $10.4M | $12.8M | $14.4M |
| Total Current Liabilities | $120.6M | $309.9M | $97.4M | $147.8M | $521.1M | $253.3M | $107.7M | $60.7M |
| Long-Term Debt | $372.2M | $383.5M | $522.4M | $689.5M | — | — | — | — |
| Total Liabilities | $571.8M | $775.2M | $704.3M | $906.2M | $1.34B | $654.8M | $476.1M | $368.1M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-199.3M | $-206.4M | $-106.8M | $-148.8M | $-211.9M | $-253.9M | $-399.4M | $-388.2M |
| Total Stockholders' Equity | $693.1M | $778.3M | $870.1M | $775.0M | $730.4M | $619.7M | $354.9M | $321.2M |